nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—DRD4—GPCR ligand binding—SCT—duodenum cancer	0.00584	0.00584	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR ligand binding—SCT—duodenum cancer	0.00576	0.00576	CbGpPWpGaD
Methotrimeprazine—DRD5—GPCR ligand binding—SST—duodenum cancer	0.00572	0.00572	CbGpPWpGaD
Methotrimeprazine—ADRA2B—G alpha (i) signalling events—SST—duodenum cancer	0.00559	0.00559	CbGpPWpGaD
Methotrimeprazine—DRD4—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00555	0.00555	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR ligand binding—SCT—duodenum cancer	0.00552	0.00552	CbGpPWpGaD
Methotrimeprazine—CHRM4—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00547	0.00547	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR ligand binding—SCT—duodenum cancer	0.00526	0.00526	CbGpPWpGaD
Methotrimeprazine—CHRM5—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00524	0.00524	CbGpPWpGaD
Methotrimeprazine—ADRA2C—G alpha (i) signalling events—SST—duodenum cancer	0.00523	0.00523	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR ligand binding—SCT—duodenum cancer	0.00519	0.00519	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR ligand binding—SCT—duodenum cancer	0.00519	0.00519	CbGpPWpGaD
Methotrimeprazine—DRD1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00499	0.00499	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00493	0.00493	CbGpPWpGaD
Methotrimeprazine—DRD3—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00493	0.00493	CbGpPWpGaD
Methotrimeprazine—DRD2—G alpha (i) signalling events—SST—duodenum cancer	0.00474	0.00474	CbGpPWpGaD
Methotrimeprazine—DRD5—GPCR downstream signaling—GAST—duodenum cancer	0.00472	0.00472	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR ligand binding—SCT—duodenum cancer	0.00468	0.00468	CbGpPWpGaD
Methotrimeprazine—CHRM2—G alpha (i) signalling events—SST—duodenum cancer	0.00458	0.00458	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR ligand binding—SCT—duodenum cancer	0.0045	0.0045	CbGpPWpGaD
Methotrimeprazine—DRD5—GPCR downstream signaling—SCT—duodenum cancer	0.00447	0.00447	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00445	0.00445	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR ligand binding—SCT—duodenum cancer	0.00438	0.00438	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR ligand binding—SCT—duodenum cancer	0.00431	0.00431	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling by GPCR—GAST—duodenum cancer	0.00428	0.00428	CbGpPWpGaD
Methotrimeprazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00427	0.00427	CbGpPWpGaD
Methotrimeprazine—ADRA2A—G alpha (i) signalling events—SST—duodenum cancer	0.00424	0.00424	CbGpPWpGaD
Methotrimeprazine—DRD4—GPCR ligand binding—SST—duodenum cancer	0.00422	0.00422	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR ligand binding—SST—duodenum cancer	0.00417	0.00417	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00415	0.00415	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00409	0.00409	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling by GPCR—SCT—duodenum cancer	0.00406	0.00406	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR ligand binding—SST—duodenum cancer	0.00399	0.00399	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR ligand binding—SCT—duodenum cancer	0.00397	0.00397	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR ligand binding—SCT—duodenum cancer	0.00391	0.00391	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR ligand binding—SCT—duodenum cancer	0.0039	0.0039	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR ligand binding—SCT—duodenum cancer	0.00389	0.00389	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR ligand binding—SCT—duodenum cancer	0.00387	0.00387	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR ligand binding—SCT—duodenum cancer	0.00384	0.00384	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR ligand binding—SCT—duodenum cancer	0.00383	0.00383	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR ligand binding—SST—duodenum cancer	0.0038	0.0038	CbGpPWpGaD
Methotrimeprazine—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00377	0.00377	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR ligand binding—SST—duodenum cancer	0.00375	0.00375	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR ligand binding—SST—duodenum cancer	0.00375	0.00375	CbGpPWpGaD
Methotrimeprazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00371	0.00371	CbGpPWpGaD
Methotrimeprazine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.0037	0.0037	CbGpPWpGaD
Methotrimeprazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00369	0.00369	CbGpPWpGaD
Methotrimeprazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00368	0.00368	CbGpPWpGaD
Methotrimeprazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00364	0.00364	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00363	0.00363	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR ligand binding—SCT—duodenum cancer	0.00355	0.00355	CbGpPWpGaD
Methotrimeprazine—DRD4—GPCR downstream signaling—GAST—duodenum cancer	0.00348	0.00348	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR downstream signaling—GAST—duodenum cancer	0.00344	0.00344	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR ligand binding—SST—duodenum cancer	0.00339	0.00339	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00337	0.00337	CbGpPWpGaD
Methotrimeprazine—DRD4—GPCR downstream signaling—SCT—duodenum cancer	0.0033	0.0033	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR downstream signaling—GAST—duodenum cancer	0.00329	0.00329	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR downstream signaling—SCT—duodenum cancer	0.00326	0.00326	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR ligand binding—SST—duodenum cancer	0.00325	0.00325	CbGpPWpGaD
Methotrimeprazine—DRD5—GPCR downstream signaling—SST—duodenum cancer	0.00323	0.00323	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR ligand binding—SST—duodenum cancer	0.00316	0.00316	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—GAST—duodenum cancer	0.00316	0.00316	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—GAST—duodenum cancer	0.00313	0.00313	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—GAST—duodenum cancer	0.00312	0.00312	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR downstream signaling—SCT—duodenum cancer	0.00312	0.00312	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR ligand binding—SST—duodenum cancer	0.00311	0.00311	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—GAST—duodenum cancer	0.00309	0.00309	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—GAST—duodenum cancer	0.00309	0.00309	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—SCT—duodenum cancer	0.003	0.003	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—GAST—duodenum cancer	0.00299	0.00299	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—SCT—duodenum cancer	0.00297	0.00297	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—SCT—duodenum cancer	0.00296	0.00296	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling by GPCR—SST—duodenum cancer	0.00294	0.00294	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—SCT—duodenum cancer	0.00293	0.00293	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—SCT—duodenum cancer	0.00293	0.00293	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR ligand binding—SST—duodenum cancer	0.00287	0.00287	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—GAST—duodenum cancer	0.00285	0.00285	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—SCT—duodenum cancer	0.00283	0.00283	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR ligand binding—SST—duodenum cancer	0.00282	0.00282	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR ligand binding—SST—duodenum cancer	0.00282	0.00282	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR ligand binding—SST—duodenum cancer	0.00281	0.00281	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—GAST—duodenum cancer	0.00281	0.00281	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—GAST—duodenum cancer	0.00281	0.00281	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR ligand binding—SST—duodenum cancer	0.0028	0.0028	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—GAST—duodenum cancer	0.00279	0.00279	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR ligand binding—SST—duodenum cancer	0.00277	0.00277	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR ligand binding—SST—duodenum cancer	0.00277	0.00277	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—SCT—duodenum cancer	0.0027	0.0027	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—GAST—duodenum cancer	0.00268	0.00268	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—SCT—duodenum cancer	0.00266	0.00266	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—SCT—duodenum cancer	0.00266	0.00266	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—SCT—duodenum cancer	0.00265	0.00265	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—GAST—duodenum cancer	0.00261	0.00261	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR ligand binding—SST—duodenum cancer	0.00257	0.00257	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—GAST—duodenum cancer	0.00257	0.00257	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—SCT—duodenum cancer	0.00254	0.00254	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—GAST—duodenum cancer	0.00254	0.00254	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—GAST—duodenum cancer	0.00253	0.00253	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—SCT—duodenum cancer	0.00247	0.00247	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—GAST—duodenum cancer	0.00244	0.00244	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—SCT—duodenum cancer	0.00243	0.00243	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—SCT—duodenum cancer	0.0024	0.0024	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—SCT—duodenum cancer	0.0024	0.0024	CbGpPWpGaD
Methotrimeprazine—DRD4—GPCR downstream signaling—SST—duodenum cancer	0.00239	0.00239	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—GAST—duodenum cancer	0.00237	0.00237	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—GAST—duodenum cancer	0.00237	0.00237	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR downstream signaling—SST—duodenum cancer	0.00235	0.00235	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—GAST—duodenum cancer	0.00233	0.00233	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—GAST—duodenum cancer	0.00233	0.00233	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—GAST—duodenum cancer	0.00232	0.00232	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—GAST—duodenum cancer	0.00232	0.00232	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—GAST—duodenum cancer	0.00231	0.00231	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—SCT—duodenum cancer	0.00231	0.00231	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—GAST—duodenum cancer	0.00229	0.00229	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—GAST—duodenum cancer	0.00228	0.00228	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR downstream signaling—SST—duodenum cancer	0.00225	0.00225	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—SCT—duodenum cancer	0.00225	0.00225	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—SCT—duodenum cancer	0.00224	0.00224	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—SCT—duodenum cancer	0.00221	0.00221	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—SCT—duodenum cancer	0.00221	0.00221	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—SCT—duodenum cancer	0.0022	0.0022	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—SCT—duodenum cancer	0.0022	0.0022	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—SCT—duodenum cancer	0.00219	0.00219	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—SCT—duodenum cancer	0.00217	0.00217	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—SST—duodenum cancer	0.00217	0.00217	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—SCT—duodenum cancer	0.00216	0.00216	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—GAST—duodenum cancer	0.00215	0.00215	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—SST—duodenum cancer	0.00215	0.00215	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—SST—duodenum cancer	0.00214	0.00214	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—SST—duodenum cancer	0.00212	0.00212	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—SST—duodenum cancer	0.00212	0.00212	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—GAST—duodenum cancer	0.00212	0.00212	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—GAST—duodenum cancer	0.00211	0.00211	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—GAST—duodenum cancer	0.00211	0.00211	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—GAST—duodenum cancer	0.0021	0.0021	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—MEN1—duodenum cancer	0.0021	0.0021	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—GAST—duodenum cancer	0.0021	0.0021	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—GAST—duodenum cancer	0.00208	0.00208	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—GAST—duodenum cancer	0.00207	0.00207	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—SST—duodenum cancer	0.00205	0.00205	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—SCT—duodenum cancer	0.00204	0.00204	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—SCT—duodenum cancer	0.00201	0.00201	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—SCT—duodenum cancer	0.002	0.002	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—SCT—duodenum cancer	0.002	0.002	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—SCT—duodenum cancer	0.00199	0.00199	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—SCT—duodenum cancer	0.00199	0.00199	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—SCT—duodenum cancer	0.00197	0.00197	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—SCT—duodenum cancer	0.00196	0.00196	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—SST—duodenum cancer	0.00195	0.00195	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—SST—duodenum cancer	0.00193	0.00193	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—SST—duodenum cancer	0.00193	0.00193	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—GAST—duodenum cancer	0.00192	0.00192	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—SST—duodenum cancer	0.00191	0.00191	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—GAST—duodenum cancer	0.00187	0.00187	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—GAST—duodenum cancer	0.00184	0.00184	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—SST—duodenum cancer	0.00184	0.00184	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—SCT—duodenum cancer	0.00182	0.00182	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—SST—duodenum cancer	0.00179	0.00179	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—SCT—duodenum cancer	0.00177	0.00177	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—GAST—duodenum cancer	0.00176	0.00176	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—SST—duodenum cancer	0.00176	0.00176	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—SCT—duodenum cancer	0.00175	0.00175	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—SST—duodenum cancer	0.00174	0.00174	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—SST—duodenum cancer	0.00173	0.00173	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—GAST—duodenum cancer	0.00168	0.00168	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—SCT—duodenum cancer	0.00167	0.00167	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—SST—duodenum cancer	0.00167	0.00167	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—GAST—duodenum cancer	0.00166	0.00166	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—GAST—duodenum cancer	0.00166	0.00166	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—SST—duodenum cancer	0.00162	0.00162	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—SST—duodenum cancer	0.00162	0.00162	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—SST—duodenum cancer	0.0016	0.0016	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—SST—duodenum cancer	0.0016	0.0016	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—SCT—duodenum cancer	0.00159	0.00159	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—SST—duodenum cancer	0.00159	0.00159	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—SST—duodenum cancer	0.00159	0.00159	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—SST—duodenum cancer	0.00158	0.00158	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—SCT—duodenum cancer	0.00157	0.00157	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—SCT—duodenum cancer	0.00157	0.00157	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—SST—duodenum cancer	0.00157	0.00157	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—SST—duodenum cancer	0.00156	0.00156	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MEN1—duodenum cancer	0.00155	0.00155	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MEN1—duodenum cancer	0.00153	0.00153	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—GAST—duodenum cancer	0.0015	0.0015	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—SST—duodenum cancer	0.00147	0.00147	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MEN1—duodenum cancer	0.00146	0.00146	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—SST—duodenum cancer	0.00145	0.00145	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—SST—duodenum cancer	0.00145	0.00145	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—SST—duodenum cancer	0.00145	0.00145	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—SST—duodenum cancer	0.00144	0.00144	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—GAST—duodenum cancer	0.00144	0.00144	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—SST—duodenum cancer	0.00144	0.00144	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—SST—duodenum cancer	0.00142	0.00142	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—SCT—duodenum cancer	0.00142	0.00142	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—SST—duodenum cancer	0.00142	0.00142	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—GAST—duodenum cancer	0.0014	0.0014	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MEN1—duodenum cancer	0.00139	0.00139	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—GAST—duodenum cancer	0.00138	0.00138	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MEN1—duodenum cancer	0.00137	0.00137	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MEN1—duodenum cancer	0.00137	0.00137	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—SCT—duodenum cancer	0.00136	0.00136	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—SCT—duodenum cancer	0.00133	0.00133	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—SST—duodenum cancer	0.00132	0.00132	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—SCT—duodenum cancer	0.00131	0.00131	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—SST—duodenum cancer	0.00128	0.00128	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—GAST—duodenum cancer	0.00127	0.00127	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—SST—duodenum cancer	0.00126	0.00126	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—GAST—duodenum cancer	0.00125	0.00125	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—GAST—duodenum cancer	0.00125	0.00125	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—GAST—duodenum cancer	0.00124	0.00124	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MEN1—duodenum cancer	0.00124	0.00124	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—GAST—duodenum cancer	0.00124	0.00124	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—GAST—duodenum cancer	0.00123	0.00123	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—GAST—duodenum cancer	0.00122	0.00122	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—SST—duodenum cancer	0.00121	0.00121	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—SCT—duodenum cancer	0.0012	0.0012	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MEN1—duodenum cancer	0.00119	0.00119	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—SCT—duodenum cancer	0.00118	0.00118	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—SCT—duodenum cancer	0.00118	0.00118	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—SCT—duodenum cancer	0.00118	0.00118	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—SCT—duodenum cancer	0.00117	0.00117	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—SCT—duodenum cancer	0.00116	0.00116	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—SCT—duodenum cancer	0.00116	0.00116	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MEN1—duodenum cancer	0.00116	0.00116	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—SST—duodenum cancer	0.00115	0.00115	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MEN1—duodenum cancer	0.00114	0.00114	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—SST—duodenum cancer	0.00114	0.00114	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—SST—duodenum cancer	0.00114	0.00114	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—GAST—duodenum cancer	0.00114	0.00114	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SCT—duodenum cancer	0.00108	0.00108	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MEN1—duodenum cancer	0.00105	0.00105	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MEN1—duodenum cancer	0.00104	0.00104	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MEN1—duodenum cancer	0.00103	0.00103	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MEN1—duodenum cancer	0.00103	0.00103	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—SST—duodenum cancer	0.00103	0.00103	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MEN1—duodenum cancer	0.00103	0.00103	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MEN1—duodenum cancer	0.00102	0.00102	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MEN1—duodenum cancer	0.00101	0.00101	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—SST—duodenum cancer	0.000986	0.000986	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—SST—duodenum cancer	0.000959	0.000959	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—SST—duodenum cancer	0.000944	0.000944	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MEN1—duodenum cancer	0.000942	0.000942	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—SST—duodenum cancer	0.00087	0.00087	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—SST—duodenum cancer	0.000856	0.000856	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—SST—duodenum cancer	0.000854	0.000854	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—SST—duodenum cancer	0.000852	0.000852	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—SST—duodenum cancer	0.000849	0.000849	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—SST—duodenum cancer	0.000841	0.000841	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—SST—duodenum cancer	0.000838	0.000838	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SST—duodenum cancer	0.000779	0.000779	CbGpPWpGaD
